Fingerprint
Dive into the research topics of 'Daratumumab in first-line combination treatment of AL amyloidosis: experience from Riga, Latvia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Daratumumab in first-line combination treatment of AL amyloidosis: experience from Riga, Latvia
Valdis Ģībietis, Kristīne Bernate, Roberts Puriņš, Ainārs Rudzītis, Aivars Lejnieks, Andris Skride
Research output: Contribution to journal › Meeting Abstract › peer-review